Hbv Hcv published presentations and documents on DocSlides.
AASLD. 2014: Abstract 1939. 3D = Ombitasvir-Pari...
Médecins du monde – Doctors of the World Inter...
Médecins du monde – Doctors of the World Inter...
qd. + SOF 400 mg . qd. N = 40. W12. 18-70 years....
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
genotypes1,2,and3.Thisreviewpresentstheavailableda...
. + Sofosbuvir +/- Ribavirin in Genotype 1. COS...
. and HIV Coinfection. NIAID ERADICATE Trial. Ph...
Open-label. W12. ≥ 18 years. Chronic HCV infect...
Barb Bancroft, RN, MSN, PNP. BBancr9271@aol.com. ...
Pegasys. ). Prepared by: David Spach, MD & H....
Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...
-. Ritonavir . and Dasabuvir . + RBV in . GT1. SA...
Bloodborne. . Pathogen Training. Biological Safe...
John Scott, MD, MSc. Associate Professor, Univers...
Open label. ≥ . 18 years, . HCV genotype 1 to ...
Hilda T Marima- Matarira. Professor of Chemical P...
Design. LDV/SOF. Open-label. ION-4 . Study. : LDV...
Open-label. Chronic HCV infection. Genotype 1 . F...
W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastro...
David Spach, MD. Clinical Director, Northwest AET...
Randomisation*. Open-label. >. 18 years. HCV ...
Open label. ≥ . 18 years, . HCV genotype 1 to ...
C. IN PEOPLE WHO USE DRUGS. Improving . Care for ...
in DAA. -Naïve GT . 1-6 . POLARIS-2. Phase 3. ...
HCV RNA ≥ 1000 IU/mL. Treatment-naïve or treat...
Randomisation. 1 : 1. 18-70 years. HCV genotype 1...
≥ 18 years. Chronic HCV infection. Genotype 1. ...
Masi. . Khaja. , M.D. Objectives . Epidemiology....
:. Navigating the Interactions. Jennifer J. Kiser...
treatment. Lisa M. Glass, MD. Clinical Lecturer. ...
Opioid Data Sharing. Objectives. Build upon the p...
By. . Dr. . Eman. . Gamal. El-Din . El-. Ahwa...
Drug Policy and Health. Joanne . Csete. , Adeeba ...
Connie Tien. June 6, 2016. Objectives. Develop a ...
Prolactin. . and the . Induction . of . Tumor Ne...
Liver Disease and Cirrhosis. Justin Mitchell, DO,...
). Slide deck prepared . by: . David H. Spach, MD...
John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Re...
Impact . of a Selective Drug Reimbursement Policy...
Copyright © 2024 DocSlides. All Rights Reserved